- $67.08m
- $56.92m
- $62.66m
- 81
- 61
- 35
- 60
Annual balance sheet for Bioqual, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
C2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 9.21 | 10.3 | 7.72 | 2.18 | 7.28 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11.5 | 15.5 | 21.2 | 26.8 | 21.3 |
| Prepaid Expenses | |||||
| Total Current Assets | 21.3 | 26.3 | 29.3 | 31.7 | 29.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5.29 | 21.5 | 23 | 30.6 | 30.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 28.3 | 49.5 | 53.4 | 63.3 | 61.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.74 | 7.68 | 8.52 | 9.77 | 8.3 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.75 | 21.4 | 19.9 | 25.7 | 23.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 24.6 | 28.2 | 33.5 | 37.7 | 37.6 |
| Total Liabilities & Shareholders' Equity | 28.3 | 49.5 | 53.4 | 63.3 | 61.3 |
| Total Common Shares Outstanding |